No profile data available.
Henry Schein, Inc. (HSIC) is a healthcare company in the healthcare device wholesale industry, based in Melville, United States, with about 25,000 full-time employees.
It reported revenue of $13.18 billion for fiscal year 2025, up 4.0% from fiscal year 2024, and net income of $398.00 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $3.46 billion, up 6.7% from a year before. Its largest business segment, Global Distribution and Value-added Services, brought in 83% of segment revenue in fiscal year 2025; United States was the largest region with 69%. Its market capitalization was $9.57 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
Henry Schein reported $13.18 billion in revenue for fiscal year 2025, up 4.0% from $12.67 billion in fiscal year 2024. In Q2 2026 revenue was $3.46 billion.
Global Distribution and Value-added Services, with $11.14 billion or 83% of segment revenue in fiscal year 2025. Next: Global Specialty Products (12%) and Global Technology (5%).
United States: 69% of revenue by region in fiscal year 2025, followed by International (31%).
$9.57 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (healthcare device wholesale) include Acme United Corporation (ACU), Vaso Corporation (VASO), Virax Biolabs Group Limited (VRAX), Fuse Medical, Inc. (FZMD).